Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antisense oligonucleotides directed to ribonucleotide reductase R2 and uses thereof in the treatment of cancer

Antisense oligonucleotides directed to ribonucleotide reductase R2 and uses thereof in the treatment of cancer

US Patent 7968526 · Granted Jun 28, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Aryl imidazoles and their use as anti-cancer agents2018
2-substituted imidazo[4,5-D]phenanthroline derivatives and their use in the trea2016
2,4,5-trisubstituted imidazoles and their use as anti-microbial agents2015
Aryl imidazoles and their use as anti-cancer agents2015
Combination preparation of a biological response modifier and an anticancer agen2013
2,4,5-trisubstituted imidazoles and their use as anti-microbial agents2013
Use of interleukin 17E for the treatment of cancer2012
Use of interleukin 17E for the treatment of cancer2012
2-indolyl imidazo [4,5-d] phenanthroline derivatives and their use in the treatm2012
2-indolyl imidazo [4,5-d] phenanthroline derivatives and their use in the treatm2012
2,4,5-trisubstituted imidazoles and their use as anti-microbial agents2011
Antitumor antisense sequences directed against R1 and R2 components of ribonucle2008